Following news reports that the NHS is likely to miss its MRSA and Clostridium difficile reduction targets, UV disinfection specialist Hanovia has received many inquiries about portable air purifiers
Designed specifically for the healthcare sector, the NQ and NQ 500 air purifiers provide increased protection from airborne pathogens including bacteria, viruses, fungi and spores.
Totally portable, they can be wheeled wherever required within a building.
They are described as ideal for localised protection in areas such as intensive care units, isolation wards (positive and negative pressure), clean rooms and laboratories.
They can also be used for more general air treatment in hospitals wards, out patient areas, waiting rooms and offices.
The devices utilise a combination of multi-level filtration, including a 99.97%, 0.3um Hepa filter, and UV disinfection.
The filters remove virtually all microorganisms as well as VOCs (volatile organic compounds), odours, chemicals, pollen and other small particles.
The four lamp UV-C disinfection system provides an extra level of protection, killing any remaining microorganisms not caught by the filters.
Recent clinical trials in hospitals in France and Canada have proven the effectiveness of the NQ and NQ 500 in reducing air borne infections.
The French trials concluded the both the NQ and NQ 500 demonstrated high efficacy at totally removing the airborne spore TCS within a very short period of time in a 'non-sealed' hospital bedroom.
MRSA - methicillin-resistant staphylococcus aureus - is a potentially lethal bacterium that is difficult to combat because it has developed a resistance to certain antibiotics.
It often strikes in hospitals where sicker and weaker people tend to be in close proximity.
